BACKGROUND: In resource-limited settings, most perinatally HIV-1-infected infants do not receive timely antiretroviral therapy because early HIV-1 diagnosis is not available or affordable. OBJECTIVE: To assess the performance of a low-cost in-house real-time polymerase chain reaction (PCR) assay to detect HIV-1 DNA in infant dried blood spots (DBS). METHODS: One thousand three hundred nineteen DBS collected throughout Thailand from non-breast-fed infants born to HIV-1-infected mothers were shipped at room temperature to a central laboratory.In-house real-time DNA PCR results were compared with Roche Amplicor HIV-1 DNA test (Version 1.5) results. In addition, we verified the Roche test performance on DBS sampled from 1218 other infants using as reference HIV serology result at 18 months of age. RESULTS: Real-time DNA PCR and Roche DNA PCR results were 100% concordant. Compared with HIV serology results, the Roche test sensitivity was 98.6% (95% confidence interval: 92.6% to 100.0%) and its specificity at 4 months of age was 99.7% (95% confidence interval: 99.2% to 99.9%). CONCLUSIONS: In-house real-time PCR performed as well as the Roche test in detecting HIV-1 DNA on DBS in Thailand. Combined use of DBS and real-time PCR assays is a reliable and affordable tool to expand access to early HIV-1 diagnosis in remote and resource-limited settings, enabling timely treatment for HIV-1-infected infants.
BACKGROUND: In resource-limited settings, most perinatally HIV-1-infectedinfants do not receive timely antiretroviral therapy because early HIV-1 diagnosis is not available or affordable. OBJECTIVE: To assess the performance of a low-cost in-house real-time polymerase chain reaction (PCR) assay to detect HIV-1 DNA in infant dried blood spots (DBS). METHODS: One thousand three hundred nineteen DBS collected throughout Thailand from non-breast-fed infants born to HIV-1-infected mothers were shipped at room temperature to a central laboratory.In-house real-time DNA PCR results were compared with Roche Amplicor HIV-1 DNA test (Version 1.5) results. In addition, we verified the Roche test performance on DBS sampled from 1218 other infants using as reference HIV serology result at 18 months of age. RESULTS: Real-time DNA PCR and Roche DNA PCR results were 100% concordant. Compared with HIV serology results, the Roche test sensitivity was 98.6% (95% confidence interval: 92.6% to 100.0%) and its specificity at 4 months of age was 99.7% (95% confidence interval: 99.2% to 99.9%). CONCLUSIONS: In-house real-time PCR performed as well as the Roche test in detecting HIV-1 DNA on DBS in Thailand. Combined use of DBS and real-time PCR assays is a reliable and affordable tool to expand access to early HIV-1 diagnosis in remote and resource-limited settings, enabling timely treatment for HIV-1-infectedinfants.
Authors: Gayle G Sherman; Peter A Cooper; Ashraf H Coovadia; Adrian J Puren; Stephanie A Jones; Mantoa Mokhachane; Keith D Bolton Journal: Pediatr Infect Dis J Date: 2005-11 Impact factor: 2.129
Authors: Heena Brahmbhatt; Godfrey Kigozi; Fred Wabwire-Mangen; David Serwadda; Tom Lutalo; Fred Nalugoda; Nelson Sewankambo; Mohamed Kiduggavu; Maria Wawer; Ronald Gray Journal: J Acquir Immune Defic Syndr Date: 2006-04-01 Impact factor: 3.731
Authors: D D Panteleeff; G John; R Nduati; D Mbori-Ngacha; B Richardson; J Kreiss; J Overbaugh Journal: J Clin Microbiol Date: 1999-02 Impact factor: 5.948
Authors: C K Cunningham; T T Charbonneau; K Song; D Patterson; T Sullivan; T Cummins; B Poiesz Journal: Pediatr Infect Dis J Date: 1999-01 Impact factor: 2.129
Authors: Christian Drosten; Marcus Panning; Jan Felix Drexler; Florian Hänsel; Celia Pedroso; Jane Yeats; Luciano Kleber de Souza Luna; Matthew Samuel; Britta Liedigk; Ute Lippert; Martin Stürmer; Hans Wilhelm Doerr; Carlos Brites; Wolfgang Preiser Journal: Clin Chem Date: 2006-04-20 Impact factor: 8.327
Authors: Michael Mauk; Jinzhao Song; Haim H Bau; Robert Gross; Frederic D Bushman; Ronald G Collman; Changchun Liu Journal: Lab Chip Date: 2017-01-31 Impact factor: 6.799
Authors: Steven R Nesheim; Laurie Linley; Kristen M Gray; Tianchi Zhang; Jing Shi; Margaret A Lampe; Lauren F FitzHarris Journal: J Acquir Immune Defic Syndr Date: 2018-01-01 Impact factor: 3.731
Authors: K Kébé; O Ndiaye; H Diop Ndiaye; P Mbakob Mengue; P M M Guindo; S Diallo; N Léye; S B Gueye; A Gaye Diallo; C Touré Kane; S Mboup Journal: J Clin Microbiol Date: 2011-05-04 Impact factor: 5.948
Authors: Rebecca E Cook; Philip J Ciampa; Mohsin Sidat; Meridith Blevins; Janeen Burlison; Mario A Davidson; Jorge A Arroz; Alfredo E Vergara; Sten H Vermund; Troy D Moon Journal: J Acquir Immune Defic Syndr Date: 2011-04 Impact factor: 3.771